These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 33728)

  • 1. [Effect of some fragments of peptide hormones on the content of biogenic monoamines from mouse brain].
    Zile RK; Odynets TG; Klusha VE
    Biokhimiia; 1979 Jan; 44(1):93-96. PubMed ID: 33728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
    Klusha B; Georgiev V; Petkov V; Markovska V
    Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spectrum of action of certain tripeptides on the central nervous system].
    Lavretskaia EF; Klusha VE; Svirskis ShV; Chamorovskaia LT; Mutsenietse RK
    Dokl Akad Nauk SSSR; 1981; 257(3):741-5. PubMed ID: 6786850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of peptide hormone fragments and thyroliberin on mouse blood glucose homeostasis].
    Myshliakova NV; Klusha VE; Chipens GI
    Biokhimiia; 1980 Oct; 45(10):1761-6. PubMed ID: 6786367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the neuro- and immunomodulator properties of low-molecular neuropeptides].
    Kukaĭn EM; Mutsenietse RK; Klusha VE
    Biull Eksp Biol Med; 1982 Aug; 94(8):79-82. PubMed ID: 6127128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoethological analysis of the effects of thyroliberin and melanostatin in a model of anxious-defensive behavior in mice].
    Poshivalov VP; Iurkevich AV; Tsakhaev GA
    Biull Eksp Biol Med; 1987 Jun; 103(6):681-3. PubMed ID: 2885047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone-induced alteration in brain transmitter metabolism and brain function.
    Telegdy G
    Endocrinol Exp; 1982 Nov; 16(3-4):217-27. PubMed ID: 6129128
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of neurohormones on the brain and the endocrine system.
    Telegdy G
    Acta Physiol Acad Sci Hung; 1980; 55(4):273-81. PubMed ID: 6110309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of hypothalamic releasing hormones in animals and men.
    Prange AJ; Wilson IC; Breese GR; Lipton MA
    Prog Brain Res; 1975; 42():1-9. PubMed ID: 729
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone.
    Osbahr AJ; Nemeroff CB; Luttinger D; Mason GA; Prange AJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):645-51. PubMed ID: 6112261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychopharmacologic spectrum of melanostatin].
    Val'dman AV; Kozlovskaia MM; Klusha VE; Svirskis ShV
    Biull Eksp Biol Med; 1980 Jun; 89(6):693-6. PubMed ID: 6104996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotropic and pituitary effects of melanostatin (MIF), thyroliberin (TRH) and structurally related peptides.
    Björkman S
    Acta Pharm Suec; 1980; 17(6):352. PubMed ID: 6111892
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone releasing activity of small peptides: effect of pyroglutamyl-seryl-glycinamide and thyrotropin releasing hormone on rat pituitaries.
    Miasiro N; Pupo AA; Paiva AC
    An Acad Bras Cienc; 1978 Dec; 50(4):581-5. PubMed ID: 107838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 7-hydroxygluacine on brain biogenic monoamines].
    Petkov VD; Grakhoska T; Konstantinova E; Petkov VV
    Farmakol Toksikol; 1985; 48(3):19-22. PubMed ID: 4029374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoaminergic mechanisms of the regulating effect of short peptides in simulating behavioral pathology].
    Val'dman AV; Kozlovskaia MM
    Patol Fiziol Eksp Ter; 1984; (3):60-7. PubMed ID: 6147809
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo [3,4-c]thieno[2,3-e][1,4]diazepine (Y-7131) on the metabolism of biogenic amines in brain.
    Setoguchi M; Takehara S; Nakajima A; Tsumagari T; Takigawa Y
    Arzneimittelforschung; 1978; 28(7):1165-9. PubMed ID: 39571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged rats.
    Stancheva SL; Petkov VD; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):14-21. PubMed ID: 3136616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.